Admission Date: [**2149-11-5**]        Discharge Date: [**2149-11-28**]  Date of Birth:  [**2149-11-5**]        Sex:  M  Service:  NBB   HISTORY OF PRESENT ILLNESS:  Baby boy [**Known lastname **] [**Name2 (NI) **] is the 1450 gm product of a 31 and [**2-8**] week di-di twin gestation born to a 37-year-old G4 P1 mom with prenatal screens B positive, antibody negative, RPR nonreactive, rubella immune, hepatitis B negative, GBS unknown.
She was treated with prednisone which was given in stress doses prior to cesarean section.
Ampicillin, erythromycin, and a single dose of betamethasone hours prior to delivery.
This infant was born was cesarean section because of abruption of placenta.
RESPIRATORY:  [**Known lastname 3979**] initially was intubated and received    one dose of surfactant for management of respiratory    distress syndrome.
He was extubated to CPAP at 24 hours    of age and remained on CPAP for a total of 12 hours at    which time he was transitioned to room air.
He is currently receiving caffeine    citrate for management of apnea-bradycardia of    prematurity.
Enteral    feedings were initiated on day of life number two.
He was treated with phototherapy    for a total of seven days.
He has not    required any blood transfusions during this hospital    course.
Blood culture remained    negative at 48 hours, at which time ampicillin and    gentamicin were discontinued.
Received vancomycin and gentamicin for    a total of 48 hours.
Feeds at discharge 150 cc per kg per day of Special Care 30 with ProMod.
Medications Fer-In-[**Male First Name (un) **] supplementation and vitamin E supplementation as well as caffeine citrate.
IMMUNIZATIONS RECEIVED:  The infant has not received any immunizations at this time.
IMMUNIZATIONS RECOMMENDED:  Synagis RSV prophylaxis should be considered from [**Month (only) **] through [**Month (only) 958**] for infants who meet any of the following three criteria: 1) born at less than 32 weeks gestation; 2) born between 32 and 35 weeks gestation with two of the following: daycare during RSV season, a smoker in the household, neuromuscular disease, airway abnormalities, or school-age siblings; or 3) with chronic lung disease.
Influenza immunization is recommended annually in the fall for all infants once they reach 6 months of age.
Before this age and for the first 24 months of the child's life, immunization against influenza is recommended for household contacts and out of home caregivers.
